Navigation Links
Tamaris Announces Foot and Leg Ulcers Pose Significant Health Threat
Date:1/27/2009

A new research study could redefine treatment for disease

Chicago, IL (Vocus) January 27, 2009 -- Americans are living longer, but living longer means our aging population is at greater risk for acquiring disease. For those with high cholesterol, diabetes and high blood pressure, Peripheral Artery Disease (PAD) is of particular concern.

PAD, often described as "poor circulation," is diagnosed when the large arteries of the leg narrow thereby restricting blood flow. The tissues then become starved of the blood, nutrients, and oxygen they need, and in its most advanced form, skin ulcers begin to develop. At this stage of PAD, called Critical Limb Ischemia (CLI), the health threat is serious.

The threat is so serious that it is difficult to grasp, but here are the facts: PAD at the stage of Critical Limb Ischemia presents the likelihood of amputation or even death. At this time, there are no prescription drugs available to effectively treat Critical Limb Ischemia, and there are limited treatments available that will delay or prevent amputation.

While these facts present a grim outlook, there is hope, thanks to a unique new opportunity. Robert Jeffrey, MD is currently conducting an investigational research study for PAD at the stage of Critical Limb Ischemia with foot and/or leg ulcers. It is anticipated that the investigational study medication may promote new blood vessel growth, and may delay the time to amputation and/or death.

The research study is currently seeking qualified participants. Individuals must be: 50 years of age or older with stable skin ulcers or non-infected gangrene on a foot or leg; diagnosed with Peripheral Arterial Disease (PAD) at the stage of Critical Limb Ischemia; and be unsuitable for by-pass or revascularization. Additional criteria also apply.

If you or someone you know suffers with skin ulcers due to PAD at the stage of Critical Limb Ischemia, please call us to determine eligibility at 1-888-853-4656 ... or visit our web site at www.tamarisstudy.com.

This research study is now underway throughout the United States, including the Chicago area.

Today's research touches our future ... and there is a possibility that the information obtained in this study may help in the future development of a new therapy for those who suffer from Critical Limb Ischemia with foot and/or leg ulcers. For more information, please contact Hal Coxon at (847) 919-1005 or via email at halcoxon(at)axmarketing.com.

Contact:
Hal Coxon
Axiom Accelerated Clinical Patient Recruitment
(847) 919-1005
halcoxon(at)axmarketing.com
www.tamarisstudy.com.

###

Read the full story at http://www.prweb.com/releases/Peripheral_Artery_Disease/Critical_Limb_Ischemia/prweb1903004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: